PUMA BIOTECHNOLOGY, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2011
Total Assets: $55.4M
Liabilities Breakdown FY2011
Total Liabilities: $1.0M
Asset Breakdown
Total Assets: $55.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $53.4M | 96.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $682.0K | 1.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.3M | 2.4% |
Liabilities Breakdown
Total Liabilities: $1.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $87.0K | 8.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $939.0K | 91.5% |